Mongaya, Rio D.
HRN: 21-16-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2024
CEFTRIAXONE 1G (VIAL)
01/17/2024
01/24/2024
IV
1.5g
OD
Nephrotic Syndrome
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes